China Universal Asset Management Company’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,114
| Closed | -$310K | – | 451 |
|
|
2023
Q4 | $310K | Buy |
13,114
+10,598
| +421% | +$250K | 0.06% | 174 |
|
|
2023
Q3 | $37.5K | Buy |
2,516
+1,238
| +97% | +$18.5K | 0.01% | 248 |
|
|
2023
Q2 | $14K | Sell |
1,278
-4
| -0.3% | -$44 | ﹤0.01% | 299 |
|
|
2023
Q1 | $11.2K | Buy |
1,282
+422
| +49% | +$3.68K | ﹤0.01% | 282 |
|
|
2022
Q4 | $5.39K | Buy |
860
+67
| +8% | +$420 | ﹤0.01% | 290 |
|
|
2022
Q3 | $3K | Buy |
+793
| New | +$3K | ﹤0.01% | 342 |
|